Saginaw, Michigan. April 4, 2019 – Graminex® LLC, producer of Graminex® Non-Solvent
Flower Pollen Extracts™, receives Health Canada Approval under the Natural and Nonprescription
Health Products Directorate (NNHPD) for its PollenBerry® Flower Pollen
Extract™. PollenBerry® is a proprietary formulation containing Graminex® G60® Flower
Pollen Extract™ and Cranberry Powder.
Health Canada’s certification guarantees that Graminex Products meet the highest quality
standards according to the guidelines of Health Canada’s Health Products and Food
Branch’s Mandate. The mandated guidelines take an integrated approach to managing the
risks and benefits in regards to supplements and health food, safeguarding the consumer
against inferior products.
“With the addition of PollenBerry®, Graminex® now has three finished goods approved by
Health Canada’s NNHPD with the associated NPN numbers. We are happy to offer this
newest product to our customers,” stated Justin E. Ritter, Regulatory Affairs.
PollenBerry® has been approved for use as a traditional and herbal medicine with
Graminex’s newest NPN license. The recommended use for PollenBerry® approved under
this NPN is to help prevent (recurrent) urinary tract infections (UTIs) in women. A secondary
claim was approved to help prevent (recurrent) urinary tract infections, which may increase
in frequency/incidence after/as a result of menopause in women.
About Graminex® LLC
Graminex® LLC is the leading producer of natural and solvent free Graminex® Flower Pollen
Extract™. Graminex® directly owns and manages more than 6,500 acres of farmland in
Northwest Ohio to meet its customer’s needs. Graminex’s® active ingredients are grown
and processed for the dietary supplement, nutraceutical, pharmaceutical, food and skin care
industries. Graminex® markets its own line of dietary supplements, focusing on prostate
care, urinary care, menopausal support, and skin care. Partnered with its distributors,
retailers and manufacturers, Graminex® non-solvent products are sold in more than 44
countries on six continents.
For further information please contact Graminex® LLC Public Relations, Colleen May at
(419) 278-1023 or by e-mail at info@graminex.com. You may also visit www.graminex.com.
